Cross-border pharma deal calls on multiple LatAm firms

Canadian publicly owned specialty pharmaceuticals company Knight Therapeutics has hired Davies Ward Phillips & Vineberg in Montréal, Pinheiro Neto Advogados in São Paulo, Ferrere (Uruguay), Brigard Urrutia in Bogotá and Beccar Varela in Buenos Aires to buy a majority stake in Uruguayan biopharmaceutical group Biotoscana, in a deal valued at 1.1 billion Brazilian reais (US$273 million).

Unlock unlimited access to all Latin Lawyer content